Abstract:Abstract KRAB containing zinc finger proteins form the largest class of mammalian transcription factors. However, the physiological or pathological functions of the majority of them are unknown. Here, we established ZFP14 as a p53 target gene that is induced upon genotoxic stress in a p53-dependent manner. To determine the function of ZFP14 in mouse and human cancer cell lines, we generated ZFP14-KO cells that showed increased senescence as well as reduced cell growth and migration. Moreover, we showed that ZFP14 negatively regulates p53, which was the cause of reduced oncogenic properties in ZFP14-KO cancer cells. Mechanistically, we found that ZFP14 modulates p53 protein stability by associating with and possibly enhancing MDM2/p53 complex integrity through its zinc finger domains. Interestingly, we found that lower expression of ZFP14 correlates with poor patient survival in multiple human cancers. Notably, in a similar fashion, mice deficient in ZFP14 were susceptible to spontaneous tumor formation, developed other abnormalities such as systemic inflammation and liver steatosis, which led to their shorter lifespan. Finally, we showed that ZFP14 regulates the expression of the HOXA gene cluster in mouse and humans, which we propose as a possible mechanism by which ZFP14 regulates tumorigenesis. Our findings suggest that ZFP14 is an important regulator of p53 and HOXA genes during inflammation and tumorigenesis. Citation Format: Shakur Mohibi, Jin Zhang, Mingyi Chen, Xinbin Chen. ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 830.

P14~(ARF) Signaling Pathway

P14ARF: The Absence that Makes the Difference

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

P14arf Interacts with E2F Factors to Form P14arf–e2f/partner‐dna Complexes Repressing E2F‐dependent Transcription

Progress in the Tumor Suppressor, ARF

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Pl4ARF and E2F1 Suppress Human Colorectal Tumorigenesis

ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.

The ARF tumor suppressor: Structure, functions and status in cancer

Transfection of Wild-Type P14arf Gene Leads to Growth Inhibition of Human Lung Cancer Cell Lines

Oncogenes & Tumor Suppressors ARF Regulates the Stability of p 16 Protein Via REG g-Dependent Proteasome Degradation

Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State

Data from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation

ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2

Transfection of Lipofectin-meidated P14arf Gene into Human Pancreatic Cancer Cells

MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells

The Deletion of P14arf Protein in Human Gliomas and Its Significance

LARP7 is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis

Biological Function and Research Progress of Tumor Suppressor Gene ARHI

Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex